Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study

INTRODUCTION: Primary breast cancer involving four or more axillary lymph nodes carries a poor prognosis. We hypothesized that use of an immunohistochemical biomarker scoring system could allow for identification of variable risk subgroups. METHODS: Patients with four or more positive axillary nodes...

Descripción completa

Detalles Bibliográficos
Autores principales: Crabb, Simon J, Bajdik, Chris D, Leung, Samuel, Speers, Caroline H, Kennecke, Hagen, Huntsman, David G, Gelmon, Karen A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374957/
https://www.ncbi.nlm.nih.gov/pubmed/18194560
http://dx.doi.org/10.1186/bcr1847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374957/
https://www.ncbi.nlm.nih.gov/pubmed/18194560
http://dx.doi.org/10.1186/bcr1847

Ejemplares similares